Wong Matthew S, Causey Thomas B, Mantzaris Nikos, Bennett George N, San Ka-Yiu
Department of Bioengineering, Rice University, 6100 Main Street, Houston, Texas 77005, USA.
Biotechnol Bioeng. 2008 Mar 1;99(4):919-28. doi: 10.1002/bit.21641.
A strain of Escherichia coli was metabolically engineered to produce poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) of specified composition between 5% and 18% HV. A gene encoding propionyl-CoA synthetase (prpE from S. enterica) was placed under the control of the IPTG-inducible tac promoter (P(taclacUV5)) while the polyhydroxyalkanoate synthesis operon (phaBCA) from R. eutropha was expressed constitutively. A strain of E. coli harboring both plasmids was grown in defined medium and PHBV was produced with specified hydroxyvalerate (HV) molar content between 5% and 18%. The molecular weight of the copolymer was approximately 700,000 across various HV contents, and average polydispersity was approximately 1.3. The majority of the PHBV production occurred during the late exponential/stationary phase. The HV content of the copolymer generally peaked early in the incubation before falling to its final value. We found that the time profiles of PrpE activity, propionyl-CoA, and acetyl-CoA were well correlated to the HV content time profile. Despite an abundance of propionyl-CoA, incorporation of HV into the copolymer was inefficient. Therefore, both the PHA operon and conditions affecting the availability of propionyl-CoA must be chosen carefully to achieve the desired HV content. The ability to engineer copolymer composition control into an E. coli strain would be useful in cases where the feedstock composition is not adjustable.
一株大肠杆菌经过代谢工程改造,以生产特定组成(HV含量在5%至18%之间)的聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(PHBV)。编码丙酰辅酶A合成酶的基因(来自肠炎沙门氏菌的prpE)置于IPTG诱导型tac启动子(P(taclacUV5))的控制之下,而来自真养产碱菌的聚羟基链烷酸酯合成操纵子(phaBCA)则组成型表达。携带这两种质粒的大肠杆菌菌株在限定培养基中培养,并生产出HV摩尔含量在5%至18%之间的特定PHBV。在不同的HV含量下,共聚物的分子量约为700,000,平均多分散性约为1.3。大部分PHBV的生产发生在指数后期/稳定期。共聚物的HV含量通常在培养早期达到峰值,然后降至最终值。我们发现PrpE活性、丙酰辅酶A和乙酰辅酶A的时间曲线与HV含量的时间曲线密切相关。尽管有大量的丙酰辅酶A,但将HV掺入共聚物的效率却很低。因此,必须谨慎选择PHA操纵子和影响丙酰辅酶A可用性的条件,以实现所需的HV含量。在原料组成不可调节的情况下,将共聚物组成控制工程引入大肠杆菌菌株的能力将很有用。